Synthesis and anti-influenza virus activity of novel pyrimidine derivatives.

Efficient synthetic routes of 2-amino-4-(omega-hydroxyalkylamino)pyrimidine derivatives were investigated in relation to the anti-influenza virus activity of these compounds. The derivatives in which cyclobutyl and cyclopentyl groups were introduced to the beta-position of the aminoalkyl group (especially the cyclobutyl group substituted by a phenylalkyl group at the 3'-position) resulted in improved antiviral potency: i.e. an average 50% effective concentration for inhibition of plaque formation (EC50, microM) of 0.1-0.01 microM for both types A and B influenza virus. The antiviral efficacies were in the order of amino group > hydroxyiminomethyl group > halogen substitution at the 5-position, and chlorine or methoxy group > hydrogen at the 6-position of the pyrimidine ring. The antiviral indices of these compounds were 2-6 with respect to the 50% inhibitory concentration for cell proliferation (IC50, microM) for growing cells, but > 500 to > 10(4) with respect to the IC50 for stationary cells, indicating that these compounds may be efficacious for the topical treatment of influenza virus infection.

[1]  W G Laver,et al.  Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. , 1997, Journal of the American Chemical Society.

[2]  E. Bisagni,et al.  Synthesis of Carbocyclic Oxetanocin Analogues as Potential Anti-HIV Agents. Part 3 , 1991 .

[3]  D. Hazuda,et al.  Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds , 1994, Antimicrobial Agents and Chemotherapy.

[4]  Laforce Fm,et al.  Influenza: virology, epidemiology, disease, and prevention. , 1994 .

[5]  W G Laver,et al.  Structures of aromatic inhibitors of influenza virus neuraminidase. , 1995, Biochemistry.

[6]  D. M. Ryan,et al.  Rational design of potent sialidase-based inhibitors of influenza virus replication , 1993, Nature.

[7]  T. Kurata,et al.  Mechanism of enhancement of the immune responses to influenza vaccine with cholera toxin B subunit and a trace amount of holotoxin. , 1995, Vaccine.

[8]  R. Lamb,et al.  The gene structure and replication of influenza virus. , 1983, Annual review of biochemistry.

[9]  Van Voris Lp,et al.  Antivirals for the chemoprophylaxis and treatment of influenza. , 1992 .

[10]  J. McCauley,et al.  Inhibition of the growth of influenza viruses in vitro by 4-guanidino-2,4-dideoxy-N-acetylneuraminic acid. , 1994, Antiviral research.

[11]  K. Oda,et al.  The PB1 subunit alone can catalyze cRNA synthesis, and the PA subunit in addition to the PB1 subunit is required for viral RNA synthesis in replication of the influenza virus genome , 1996, Journal of virology.

[12]  Y. Shealy,et al.  Carbocyclic analogs of guanosine and 8-azaguanosine. , 1973, Journal of pharmaceutical sciences.

[13]  E. Bisagni,et al.  New cyclobutyl analogs of adenosine and guanosine. Part 1. Synthesis of the 9‐[3,3‐bis(hydroxymethyl)cyclobutyl]purine nucleoside analogs , 1990 .

[14]  S. Gravenstein,et al.  Efficacy of an Influenza Hemagglutinin‐Diphtheria Toxoid Conjugate Vaccine in Elderly Nursing Home Subjects During an Influenza Outbreak , 1994, Journal of the American Geriatrics Society.

[15]  T. Daikoku,et al.  Anti-herpesvirus activity of carbocyclic oxetanocin G in vitro. , 1989, The Journal of antibiotics.

[16]  M. Saijo,et al.  Antiviral activity of oxetanocins against varicella-zoster virus , 1991, Antimicrobial Agents and Chemotherapy.

[17]  E. Bisagni,et al.  SYNTHESIS OF 9-(HEXANE-1,6-DIOL-3-YL)PURINES, A NOVEL SERIES OF ACYCLIC NUCLEOSIDE ANALOGS AND ANTIVIRAL EVALUATION , 1990 .

[18]  F. Hayden,et al.  Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. , 1989, The New England journal of medicine.

[19]  E. Bisagni,et al.  New Cyclobutyl Analogs of Adenosine and Guanosine. Part 1. Synthesis of the 9‐(3,3‐Bis(hydroxymethyl)cyclobutyl)purine Nucleoside Analogs. , 1991 .

[20]  N. Bovin,et al.  Monovalent and polymeric 5N-thioacetamido sialosides as tightly-bound receptor analogs of influenza viruses. , 1997, Antiviral research.

[21]  Y. Hayashi,et al.  Enantio- and diastereo-selective synthesis of carbocyclic oxetanocin analogues , 1989 .

[22]  A. Matsuda,et al.  Antiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6'-(R)-6'-C-methylneplanocin A against several ortho- and paramyxoviruses , 1992, Antimicrobial Agents and Chemotherapy.

[23]  H. Yamada,et al.  Mode of action of the anti-influenza virus activity of plant flavonoid, 5,7,4'-trihydroxy-8-methoxyflavone, from the roots of Scutellaria baicalensis. , 1995, Antiviral research.

[24]  K. Morokuma,et al.  Enhancing effects of pertussis toxin B oligomer on the immunogenicity of influenza vaccine administered intranasally. , 1994, Vaccine.

[25]  A. Ishihama,et al.  The RNA polymerase PB2 subunit is not required for replication of the influenza virus genome but is involved in capped mRNA synthesis , 1995, Journal of virology.

[26]  A. Monto,et al.  Implications of viral resistance to amantadine in control of influenza A. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  H. Maassab,et al.  New aspects of influenza viruses , 1992, Clinical Microbiology Reviews.

[28]  T. Suzutani,et al.  Effects of various nucleosides on antiviral activity and metabolism of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against herpes simplex virus types 1 and 2 , 1988, Antimicrobial Agents and Chemotherapy.